Drug Trial Radar · NCT07754461
A Study to Test Whether Survodutide Helps People With Type 2 Diabetes Control Their Blood Sugar
Last checked: Nov 19, 2026Latest source record: Nov 13, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Recruiting
Enrollment
600
Planned (sponsor's estimate)
Start
Aug 24, 2026
Primary completion
Jan 17, 2028
Study completion May 1, 2028
Sponsor
- Lead sponsor
- Boehringer IngelheimBoehringer Ingelheim
- Sponsor type
- Industry
- First posted
- Aug 10, 2026
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Quadruple (participant, care provider, investigator, outcomes assessor)
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This study aims to find out whether a study medicine called survodutide helps people control their blood sugar. Adults who live with type 2 diabetes and with a body mass index (BMI) of 23 kg/m2 or higher can join. The study has 3 parts. In each part the study compares survodutide with placebo. Survodutide is being developed to treat several health problems including type 2 diabetes. Placebo looks like survodutide but does not contain any medicine. Depending on a person's diabetes treatment, a person will be assigned either to * Part A: healthy eating and physical activity * Part B: diabetes tablets (no injection of insulin) * Part C: injection of insulin (with or without diabetes tablets) Participants are randomly put into 1 of 3 groups, which means the group is chosen by chance. Two groups of participants get survodutide at different dose levels, and the third group gets placebo as injection under the skin once a week. You have a 2 in 3 chance of getting survodutide. During the study, participants continue their regular diabetes treatment. Participants are in the study for about 1 year and 2 months. During this time, they attend up to 12 visits at the site and receive at least 9 phone calls. Study doctors regularly test participants' blood sugar by checking their HbA1c values and other laboratory test results. The study doctor also regularly checks participants' health and takes note of any changes. For each study part, the results will be compared between the survodutide and the placebo group to see whether the treatment works.
Conditions
- Type 2 Diabetes
Interventions
PlaceboDrug
Placebo
SurvodutideDrug
Survodutide
Primary outcomes
What the sponsor says the trial is designed to measure.
- Absolute change in glycosylated haemoglobin A1c (HbA1c) (%) from baseline to Week 41Time frame: At baseline and Week 41.
Locations
121 sites in 6 countries. Site status is shown where the registry gives one.
Cahaba Research, Inc. - Trussville Location
Birmingham, Alabama · Recruiting
Mission Research Institute - Gilbert
Gilbert, Arizona · Recruiting
Helios Clinical Research - Paradise Valley
Paradise Valley, Arizona · Recruiting
Arizona Liver Health - Peoria 85381
Peoria, Arizona · Recruiting
Helios Clinical Research - Phoenix
Phoenix, Arizona · Recruiting
Woodland International Research Group, Inc.
Little Rock, Arkansas · Recruiting
San Fernando Valley Health
Canoga Park, California · Recruiting
John Muir Physician Network Clinical Research Center
Concord, California · Recruiting
Neighborhood Healthcare - Escondido
Escondido, California · Recruiting
Clinical Trials Research - Lincoln
Lincoln, California · Recruiting
ARK Clinical Research
Long Beach, California · Recruiting
Infinity Clinical Research
Norco, California · Recruiting
Valley Clinical Trials, Inc.
Northridge, California · Recruiting
Fomat Medical Research
Oxnard, California · Recruiting
Paradigm Clinical Research - San Diego
San Diego, California · Not yet recruiting
Encompass Clinical Research, Spring Valley
Spring Valley, California · Recruiting
University Clinical Investigators, Inc.
Tustin, California · Recruiting
Diablo Clinical Research
Walnut Creek, California · Recruiting
Focus Clinical Research
West Hills, California · Recruiting
Clinical Research of West Florida, Inc.
Clearwater, Florida · Recruiting
Northeast Research Institute
Fleming Island, Florida · Recruiting
Covenant Metabolic Specialists, LLC - Fort Myers
Fort Myers, Florida · Recruiting
Encore Medical Research
Hollywood, Florida · Recruiting
Northeast Research Institute
Jacksonville, Florida · Recruiting
Accel Research Sites - Lakeland
Lakeland, Florida · Recruiting
Clinical Research of Central Florida - Lakeland
Lakeland, Florida · Recruiting
Tampa Bay Medical Research - Largo
Largo, Florida · Recruiting
New Horizon Research Center-Miami-69732
Miami, Florida · Recruiting
South Broward Research
Miramar, Florida · Recruiting
Covenant Metabolic Specialists, LLC - Brandon
Riverview, Florida · Recruiting
Covenant Metabolic Specialists, LLC - Sarasota
University Park, Florida · Recruiting
Metabolic Research Institute, Inc.
West Palm Beach, Florida · Recruiting
Encore Medical Research - Weston
Weston, Florida · Recruiting
Conquest Research
Winter Park, Florida · Recruiting
Centricity Research, Endocrine Consultants
Columbus, Georgia · Recruiting
Javara-Fayetteville-67354
Fayetteville, Georgia · Recruiting
Balanced Life Health Care Solutions
Lawrenceville, Georgia · Not yet recruiting
Rophe Adult and Pediatric Medicine
Union City, Georgia · Not yet recruiting
Pacific Diabetes & Endocrine Center
Honolulu, Hawaii · Not yet recruiting
Elite Clinical Trials - Blackfoot
Blackfoot, Idaho · Recruiting
Showing 40 of 121 sites, US sites first. The full list is on the registry record.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.